Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
33.33
-0.38 (-1.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Stoke Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Net Income
-6.89-88.98-104.7-101.07-85.81
Upgrade
Depreciation & Amortization
1.772.182.471.550.97
Upgrade
Loss (Gain) From Sale of Assets
0.15-0-0.03
Upgrade
Asset Writedown & Restructuring Costs
0.7----
Upgrade
Loss (Gain) From Sale of Investments
-1.13-1.64-0.33-0.210.14
Upgrade
Stock-Based Compensation
32.2427.4725.2622.8516.45
Upgrade
Other Operating Activities
2.412.272.261.991.26
Upgrade
Change in Accounts Receivable
-4.27-0.05---
Upgrade
Change in Accounts Payable
21.293.09-3.21-3.532.9
Upgrade
Change in Unearned Revenue
-0.13-29.39-3.3551.74-
Upgrade
Change in Other Net Operating Assets
-0.55-1.790.53-5.18-2.85
Upgrade
Operating Cash Flow
45.59-86.85-81.07-31.87-66.91
Upgrade
Capital Expenditures
-0.67-0.2-1.62-3.96-1.2
Upgrade
Investment in Securities
-186.14-107.27107.56-41.92-75.23
Upgrade
Investing Cash Flow
-186.81-107.48105.95-45.88-76.43
Upgrade
Issuance of Common Stock
97.39131.0953.0146.411.29
Upgrade
Other Financing Activities
---0-0
Upgrade
Financing Cash Flow
97.39131.0953.0146.411.28
Upgrade
Net Cash Flow
-43.84-63.2377.89-31.34-142.05
Upgrade
Free Cash Flow
44.92-87.05-82.68-35.83-68.11
Upgrade
Free Cash Flow Margin
24.36%-238.15%-941.72%-288.82%-
Upgrade
Free Cash Flow Per Share
0.76-1.61-1.88-0.92-1.85
Upgrade
Levered Free Cash Flow
33.02-26.46-45.1-36.15-34.78
Upgrade
Unlevered Free Cash Flow
33.03-26.45-45.07-36.15-34.78
Upgrade
Change in Working Capital
16.35-28.14-6.0343.020.05
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.